Ha Kung Wong Named to The National Law Journal’s Inaugural List of Elite Boutique Trailblazers

National Law Journal
September 6, 2017


Linda Ficano
Fitzpatrick, Cella, Harper & Scinto
(212) 218-2284


Ha Kung Wong Named to The National Law Journal’s
Inaugural List of Elite Boutique Trailblazers

New York, NYSeptember 6, 2017—Fitzpatrick, Cella, Harper & Scinto is pleased to announce that partner Ha Kung Wong has been named to The National Law Journal’s inaugural list of Elite Boutique Trailblazers. He is one of only 23 attorneys selected to receive this award, which recognizes movers and shakers in the legal industry who have made an impact in the boutique sector through new types of strategies or innovative court cases.

Ha Kung was a key player on the Fitzpatrick team for a crucial patent infringement case for AstraZeneca involving its blockbuster drug Prilosec. AstraZeneca had already lost two similar cases. Ha Kung handled key witness testimony at trial, where the court sided with AstraZeneca—a stunning victory that helped cement Fitzpatrick’s reputation as the preeminent firm for Hatch-Waxman litigation.

Ha Kung has been a partner at Fitzpatrick for over nine years. He has served on the firm’s Recruiting Committee for 14 years, currently serves as its chair and also sits on the firm’s Management Committee. Ha Kung has led efforts to attract diverse candidates, spearheading a collaborative process to draft the firm’s Diversity Statement—a document that guides all recruiting efforts at Fitzpatrick.

He practices general intellectual property law with an emphasis on complex patent and trade secret litigation in pharmaceuticals, biologics and chemistry. Cases that Ha Kung has litigated include those related to proton pump inhibitors, anti-epileptic drugs, anti-tussives and other pharmaceuticals. Ha Kung also has extensive experience with inter partes review (IPR), intellectual property counseling, pre-suit investigations, licensing and due diligence.

Ha Kung is the recipient of the 2017 ILO Client Choice Individual Award for Intellectual Property in New York. He currently serves on the faculty for NITA (the National Institute of Trial Advocacy) and Lawline, and has been named to Lawline’s “Furthered 40” list, which honors excellence in furthering education. He is also an Advisory Board Member for The Center for Biosimilars.

The National Law Journal’s 2017 Elite Boutique Trailblazers list is available here.


About Fitzpatrick, Cella, Harper & Scinto:

At Fitzpatrick, Cella, Harper & Scinto (www.fitzpatrickcella.com), IP is not just a practice area – it is the firm’s sole focus. Founded in 1971, Fitzpatrick is a leading national intellectual property law firm with offices in New York, Costa Mesa, California, and Washington, D.C. It has one of the premier patent litigation and prosecution practices, which covers the spectrum of intellectual property services, including applying for patent and trademark protection, litigation in U.S. district courts and the International Trade Commission, appeals, interferences, post-grant patent challenges (e.g., IPRs), alternative dispute resolution, licensing, opinions, corporate transactions, and due diligence. Fitzpatrick represents an international client base from Fortune 500 companies to start-up companies.